• Home
• News
• About Us
• Contact

Search

Tag Cloud

anthrax Strategic National Stockpile Training exercise Bioterror Biomagnetics National Research Council Homeland Security Biodefense lab Army Medical Research Institute antibiotics Emergency preparedness research Bioweapons NIAID smallpox Detection technology CDC TSA Defense Dept IAEM FEMA immunization Ebola Ricin Hendra Plague treaty West Nile Camouflage Paint Marburg antidote weapons destruction Sarin VHF viruses chemical disposal dna technology prevention Robotics Technology research grants tularemia weapons control foot and mouth disease decontamination E. coli Iraq missile defense Bio-Rescue Dengue fever Botulinum toxin antiviral molecular diagnostics Infectious disease

Subscribe to our newsletter

RSS Feed

Biothreats to agriculture highlighted
by Pat Dulnier on March 1, 2010

The International Agri-Center in Tulare, California was recently visited by government officials in an attempt to raise awareness of the threat, impact and response needs in the face of potential terrorist attacks on the agricultural sector.

Further review sought of 2001 anthrax mailings
by Pat Dulnier on February 26, 2010

Further review is being sought by the United States House of Representatives over the 2001 anthrax mailings that resulted in five deaths that was recently closed by the FBI.

HHS Sec. Sebelius speaks on health preparedness
by Pat Dulnier on February 19, 2010

U.S. Health and Human Services Secretary Kathleen Sebelius spoke about efforts to strengthen health preparedness at this week's 2010 Public Health preparedness Summit.

Smiths Detection to distribute BioCheck powder screening test kits
by Pat Dulnier on February 18, 2010

A worldwide distribution agreement has been announced by Smiths Detection with 20/20 BioResponse for its patented BioCheck powder screening test kits

Calif. water utility secures unmanned stations from biothreats
by Pat Dulnier on February 11, 2010

The investor-owned Alco Water Service has begun using an RFID-based system for security at its unmanned pump stations throughout Salinas, Calif., bringing them into compliance with the Bioterrorism Act of 2002.

Denmark institutes new rules for handling certain biological substances
by Pat Dulnier on February 5, 2010

Beginning May 1, hospitals, researchers and companies in Denmark will be required to apply for a license to use certain substances that could be used to make biological weapons.

New study shed light on how citizens will react to bio-outbreak
by Pat Dulnier on February 3, 2010

A new study has highlighted how people behave during pandemics and potentially paved the way to predict protective behaviors by identifying key demographic and psychological factors, giving light on how populations might react to a bioterror event.

England reveals increased monitoring for dirty bombs, bioweapons
by Pat Dulnier on January 19, 2010

Major British ports have had high-tech machines installed to detect any materials that could potentially be used to build "dirty bombs," it has been revealed.

Source of 1981 anthrax attack in Scotland revealed
by Pat Dulnier on January 15, 2010

Newly uncovered secret files have revealed that the culprits of a 1981 anthrax attack in Scotland were a shadowy group known as the Scottish Civilian Army.

Aethlon Medical advances therapeutic device for biological warfare pathogens
by Pat Dulnier on January 14, 2010

A company developing a therapeutic device meant to treat acute and chronic viral infections, biological warfare pathogens and other conditions has issued a research update.

Anthrax scare in Britain's House of Commons
by Pat Dulnier on December 31, 2009

An envelope sent to Britain's Communities minister Shahid Malik was found to be filled with a white power and triggered an anthrax scare at the House of Commons.

Third anthrax death in Glasgow
by Pat Dulnier on December 30, 2009

Doctors have confirmed that a heroin user who died last week was infected with anthrax, bringing the total deaths from infections to three.

Third anthrax infection identified in Glasgow
by Pat Dulnier on December 22, 2009

A heroin user has been identified as the third case of anthrax infection in Glasgow, Scotland by health officials.

New tools will fight bioterrorism in food supply chain
by Pat Dulnier on December 22, 2009

A new set of tools designed by the FDA and the United States Department of Agriculture aims to aid food-animal producers in mitigating risk of bioterrorism on the food production process.

- British Royal Society calls for more realistic bio-attack exercises
by Pat Dulnier on December 16, 2009

Britain's Royal Society has warned that more realistic exercises need to be conducted to improve emergency responses to both chemical and biological attacks.

Sen. Mark Pryor announces plans for bill that would make attacks eligible for federal emergency assistance
by Pat Dulnier on December 14, 2009

U.S. Sen. Mark Pryor has announced plans to file a bill that would make terrorist attacks, public health emergencies and man-made disasters eligible for federal emergency assistance.

Singapore debuts bioterror attack tracing software
by Pat Dulnier on December 11, 2009

DSO National Laboratories, Singapore's defense research and development organization, has created software to monitor the spread of chemical agents in real-time.

Brookline, Mass., stages bioterror drill
by Pat Dulnier on December 3, 2009

More than 100 volunteers will take part in a rapid vaccination program in Brookline, Mass., this weekend to prepare the town for a serious pandemic situation or a bioterrorist attack.

UAE officials given bioterrorism training
by Pat Dulnier on November 30, 2009

The United Arab Emirates is not currently facing a bioterrorism threat but it is not taking any chances.

Tiny silicon chip to increase first responders' ability to diagnose bio attack
by Pat Dulnier on November 24, 2009

A tiny chip based on silicon produced by IBM's research labs in Zurich could soon be used by first responders to quickly diagnose dozens of diseases faster and with less blood required than normal.

Gene synthesis firms unite to tighten security
by Pat Dulnier on November 23, 2009

The five companies - DNA 2.0, GeneArt, GenScript, Integrated DNA Technologies and Blue Heron Biotechnology - provide 80 percent of global gene synthesis capacity.

Maryland biopharmaceutical company purchases East Baltimore bioscience center
by Pat Dulnier on November 17, 2009

A Rockville, Maryland based biopharmaceutical company has purchased the East Baltimore bioscience nonprofit MdBio Foundation's 55,000-square-foot BioProcessing Center in East Baltimore.

Emergent BioSolutions acquires manufacturing facility from MdBio
by Pat Dulnier on November 13, 2009

ROCKVILLE, Md. — Emergent BioSolutions Inc. has completed the acquisition of a 55,000-square-foot manufacturing facility from MdBio Foundation and the land on which the facility stands from the city of Baltimore.

Kent State University becomes 2nd in U.S. to offer biosafety training
by Pat Dulnier on November 12, 2009

KENT, Ohio — The increasing number of high-containment laboratories and the constant threat from emerging diseases and bioterrorism require more extensive biosafety training of the highest caliber.

Scientists Announce Possible Treatment for Deadly Virus
by Pat Dulnier on November 11, 2009

A team of Australian and U.S. scientists believe they have found an antibody that could protect humans from the deadly Hendra virus, Australia's Northern Miner reported yesterday.

Ricin antidote to enter production
by Pat Dulnier on November 10, 2009

An anti-toxin that protects against ricin poisoning is to move into production for the first time, BBC News reported Nov. 11.

Cox elected chairman of IAEM
by Pat Dulnier on November 6, 2009

Rick Cox, senior planner of IEM Inc., has been elected global board chairman of the International Association of Emergency Managers.

Committee sends Weapons of Mass Destruction bill to Senate
by Pat Dulnier on November 5, 2009

WASHINGTON, D.C.-- The Senate Homeland Security and Governmental Affairs Committee on Nov. 4 recommended the Weapons of Mass Destruction Prevention and Preparedness Act for a vote by the full Senate.

Uganda officials fear plague outbreak as rainy season begins
by Pat Dulnier on October 28, 2009

KAMPALA, Uganda — Health officials have launched a plague prevention campaign in the Nebbi district, which was most recently hit by the vector-borne disease a year ago.

JPL develops high-speed test to improve pathogen decontamination
by Pat Dulnier on October 26, 2009

A chemist at NASA's Jet Propulsion Laboratory in Pasadena, Calif., has developed a technology intended to rapidly assess any presence of microbial life on spacecraft.

Army breaks ground for bigger biodefense lab at Fort Detrick
by Pat Dulnier on October 19, 2009

FREDERICK, Md. — The U.S. military's flagship biological defense agency has broken ground on a $680 million headquarters building designed for expanded Army research on the world's deadliest pathogens.

Napolitano announces $88 million for port inspection technology
by Pat Dulnier on October 18, 2009

Department of Homeland Security Secretary Janet Napolitano announced $88 million in funding for non-intrusive Inspection equipment to scan commercial traffic for contraband through X-ray and other imaging technologies.

States, municipalities could get biological agent detection kits
by Pat Dulnier on October 17, 2009

Universal Detection Technology, a developer of early warning monitoring technologies and counter-terrorism training programs, announced Oct. 19 that it is preparing for inclusion in a disaster preparedness contract established in New York after Sept. 11,

Emergent BioSolutions submits its plan for vaccine contract to FDA
by Pat Dulnier on May 13, 2009

ROCKVILLE, Md. — Emergent BioSolutions Inc. announced May 13, 2009, that it has submitted to the U.S. Food and Drug Administration a development plan for the company’s recombinant protective antigen anthrax vaccine candidate.

Emergent BioSolutions acquires advanced anthrax vaccine candidate, technology
by Pat Dulnier on May 5, 2008

ROCKVILLE, Md. — Emergent BioSolutions Inc. announced that it has completed the acquisition of all assets and rights related to a recombinant protective antigen (rPA) anthrax vaccine product candidate and related technology from VaxGen Inc.